RHOA and diabetes mellitus: In conclusion, the present studies demonstrate that the expression of RhoA is negatively regulated by miR-133a and a decrease in its expression in diabetes leads to an increase in RhoA expression, agonist-induced Rho kinase activity, and muscle contraction.